David Feinberg
Email
dfeinberg@mednet.ucla.edu
Phone
Work Phone Number:
(310) 267-3516
(310) 267-9315
Address
Mailing Address:
757 Westwood Plaza, Suite 1320Ronald Reagan UCLA Medical CenterMail Code 740030Los Angeles, CA 90095UNITED STATES
David Feinberg, MD, MBA is the chief executive officer of the UCLA Hospital System and associate vice chancellor. Prior to assuming the leadership role of CEO for UCLA Hospitals, Dr. Feinberg was the medical director of the Resnick Neuropsychiatric Hospital (NPH) at UCLA.
He has been a faculty member in the Department of Psychiatry at the David Geffen School of Medicine since 1994. He is triple board certified in Child and Adolescent Psychiatry, Adult Psychiatry, and Addiction Psychiatry. Dr. Feinberg also has his master of business admninstration from Pepperdine University.
Dr. Feinberg areas of expertise include Attention Deficit/Hpyeractivity Disorder, Adolescent Substance Abuse and the business of medicine.
Publications
Feinberg David T 2007: a year of change?.
Journal of child and adolescent psychopharmacology.
2007; 17(2):
257.
Feinberg David T Consumer-directed health care: not quite the cure yet..
Journal of child and adolescent psychopharmacology.
2007; 17(1):
143-4.
Feinberg David T The cost of over-the-counter substance abuse..
Journal of child and adolescent psychopharmacology.
2006; 16(6):
801-2.
Feinberg David T Two giant steps forward..
Journal of child and adolescent psychopharmacology.
2006; 16(4):
503-4.
Feinberg David T Are doctors elastic?.
Journal of child and adolescent psychopharmacology.
2006; 16(1-2):
5-6.
Feinberg David T Insure kids now..
Journal of child and adolescent psychopharmacology.
2006; 16(3):
238.
Feinberg David T "Daddy, what is erectile dysfunction?" Direct-to-consumer advertising
will be changing..
Journal of child and adolescent psychopharmacology.
2005; 15(6):
866-8.
Feinberg David T Consumer driven health care..
Journal of child and adolescent psychopharmacology.
2005; 15(5):
717-9.
Feinberg David T Crossing the health-care quality chasm: When will evidenced-based
medicine take hold?.
Journal of child and adolescent psychopharmacology.
2005; 15(4):
529-31.
Feinberg David T Dr. Robin Hood to cure California's mentally ill..
Journal of child and adolescent psychopharmacology.
2005; 15(2):
155-6.
Feinberg David T Managed care. Crossroads..
Journal of child and adolescent psychopharmacology.
2005; 15(1):
3-4.
Feinberg David T 2002 annual reports: money and pharmaceuticals..
Journal of child and adolescent psychopharmacology.
2004; 14(1):
9-11.
Feinberg David T Are "carve outs" in or out?.
Journal of child and adolescent psychopharmacology.
2004; 14(2):
161-3.
Feinberg David T Medicare-approved prescription drug discount card program: will this
really help our seniors?.
Journal of child and adolescent psychopharmacology.
2004; 14(3):
348-9.
Pataki Caroly S, Feinberg David T, McGough James J New drugs for the treatment of attention-deficit/hyperactivity
disorder..
Expert opinion on emerging drugs.
2004; 9(2):
293-302.
Feinberg David T, Miller Matt Quality is in the eye of the beholder..
Journal of child and adolescent psychopharmacology.
2004; 14(4):
539-41.
Feinberg David T Formularies and the like: what managed care companies are doing to
keep pharmacy costs down..
Journal of child and adolescent psychopharmacology.
2003; 13(2):
119-21.
Feinberg David T Opportunity from crisis: how medical cost offset helps our patients
and may help save the system..
Journal of child and adolescent psychopharmacology.
2003; 13(3):
213-5.
Feinberg David T The real cost of pediatric bipolar disorder..
Journal of child and adolescent psychopharmacology.
2003; 13(4):
431-3.
